NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies
Results could play a role in bringing targeted treatments to patients with certain gene abnormalities, regardless of their cancer type.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Genetics | National Institutes of Health (NIH)